Evidence map›Paper›PMID 25634561›Full record

ArticleHuman molecular genetics2015

Mosaic structural variation in children with developmental disorders.

Daniel A King, Wendy D Jones, Yanick J Crow, Anna F Dominiczak, Nicola A Foster, Tom R Gaunt, Jade Harris, Stephen W Hellens, Tessa Homfray, Josie Innes and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Somatic copy number variants in neuropsychiatric disorders.Current opinion in genetics & development · 2021
    Review
  15. Article
  16. Article
  17. The role of somatic mosaicism in brain disease.Current opinion in genetics & development · 2020
    Review
  18. Mosaicism in Human Health and Disease.Annual review of genetics · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 17 institutions in 1 country.

Daniel A KingWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Wendy D JonesWellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, UK.
Yanick J CrowManchester Centre for Genomic Medicine, Central Manchester University Hospitals, NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester M13 9WL, UK.
Anna F DominiczakCollege of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Nicola A FosterUniversity Hospitals of Leicester, NHS Trust, Leicester Royal Infirmary, Leicester LE1 5WW, UK.
Tom R GauntMRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.
Jade HarrisManchester Centre for Genomic Medicine, Central Manchester University Hospitals, NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester M13 9WL, UK.
Stephen W HellensNorthern Genetics Service, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne NE1 3BZ, UK.
Tessa HomfraySouthwest Thames Regional Genetics Centre, St George's Healthcare NHS Trust, London SW17 0RE, UK.
Josie InnesManchester Centre for Genomic Medicine, Central Manchester University Hospitals, NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester M13 9WL, UK.
Elizabeth A JonesManchester Centre for Genomic Medicine, Central Manchester University Hospitals, NHS Foundation Trust, Manchester Academic Health Science Centre (MAHSC), Manchester M13 9WL, UK, Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, MAHSC, Manchester M13 9WL, UK.
Shelagh JossWest of Scotland Clinical Genetics Service, Southern General Hospital, Glasgow DD1 9SY, UK.
Abhijit KulkarniSouthwest Thames Regional Genetics Centre, St George's Healthcare NHS Trust, London SW17 0RE, UK.
Sahar MansourSouthwest Thames Regional Genetics Centre, St George's Healthcare NHS Trust, London SW17 0RE, UK.
Andrew D MorrisSchool of Molecular, Genetic and Population Health Sciences, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK.
Michael J ParkerSheffield Clinical Genetics Service, Sheffield Children's Hospital, Western Bank, Sheffield, UK.
David J PorteousMedical Genetics Section, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
Hashem A ShihabMRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.
Blair H SmithSchool of Medicine, Dundee University, Mackenzie Building, Kirsty Semple Way, Ninewells Hospital and Medical School, Dundee DD2 4RB, UK.
Katrina Tatton-BrownSouthwest Thames Regional Genetics Centre, St George's Healthcare NHS Trust, London SW17 0RE, UK.
John L TolmieWest of Scotland Clinical Genetics Service, Southern General Hospital, Glasgow DD1 9SY, UK.
Maciej TrzaskowskiKing's College London, MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London SE5 8AF, UK and.
Pradeep C VasudevanUniversity Hospitals of Leicester, NHS Trust, Leicester Royal Infirmary, Leicester LE1 5WW, UK.
Emma WakelingNorth West Thames Regional Genetics Service, North West London Hospitals NHS Trust, Watford Rd, Harrow HA1 3UJ, UK.
Michael WrightNorthern Genetics Service, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne NE1 3BZ, UK.
Robert PlominKing's College London, MRC Social, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London SE5 8AF, UK and.
Nicholas J TimpsonMRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK.
Matthew E Hurles
Deciphering Developmental Disorders Study
Manchester Academic Health Science Centre · GBUniversity of Bristol · GBWellcome Sanger Institute · GBKing's College London · GBNewcastle upon Tyne Hospital · GBSouthern General Hospital · GBSouth West London and St George's Mental Health NHS Trust · GBSt George’s University Hospitals NHS Foundation Trust · GBLeicester Royal Infirmary · GBLondon North West Healthcare NHS Trust · GBMRC Institute of Genetics and Molecular Medicine · GBNinewells Hospital · GBSheffield Children's Hospital · GBUniversity Hospitals of Leicester NHS Trust · GBUniversity of Edinburgh · GBUniversity of Glasgow · GBUniversity of Manchester · GB

Funding

Chief Scientist Office CZD/16/6Chief Scientist Office CZD/16/6/4Medical Research Council G0500079Medical Research Council G0901245Medical Research Council MC_PC_15018Medical Research Council MC_UU_12013/3Medical Research Council MC_UU_12013/8Wellcome Trust 102215Wellcome Trust 102215/2/13/2Wellcome Trust WT098051
6 · The paper itself

Abstract

Delineating the genetic causes of developmental disorders is an area of active investigation. Mosaic structural abnormalities, defined as copy number or loss of heterozygosity events that are large and present in only a subset of cells, have been detected in 0.2-1.0% of children ascertained for clinical genetic testing. However, the frequency among healthy children in the community is not well characterized, which, if known, could inform better interpretation of the pathogenic burden of this mutational category in children with developmental disorders. In a case-control analysis, we compared the rate of large-scale mosaicism between 1303 children with developmental disorders and 5094 children lacking developmental disorders, using an analytical pipeline we developed, and identified a substantial enrichment in cases (odds ratio = 39.4, P-value 1.073e - 6). A meta-analysis that included frequency estimates among an additional 7000 children with congenital diseases yielded an even stronger statistical enrichment (P-value 1.784e - 11). In addition, to maximize the detection of low-clonality events in probands, we applied a trio-based mosaic detection algorithm, which detected two additional events in probands, including an individual with genome-wide suspected chimerism. In total, we detected 12 structural mosaic abnormalities among 1303 children (0.9%). Given the burden of mosaicism detected in cases, we suspected that many of the events detected in probands were pathogenic. Scrutiny of the genotypic-phenotypic relationship of each detected variant assessed that the majority of events are very likely pathogenic. This work quantifies the burden of structural mosaicism as a cause of developmental disorders.

Indexed as

Genomic Structural VariationLoss of HeterozygosityMosaicismAdolescentAdultAgedAged, 80 and overCase-Control StudiesChildChild, PreschoolDevelopmental DisabilitiesFemaleGenetic TestingHumansInfantInfant, Newborn

Identifiers

PMID25634561
PMCPMC4406290
OpenAlexW2169730568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.